StockData
Stryker Corp logo

Stryker Corp

SYKNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 19/3024% below fair value
$306.81+14.95 (+5.12%)

Close on Nov 2, 2026Market cap $117.68BP/E 32.7Yield –

Stryker MedSurg and Neurotechnology — Segment Revenue by Year

MedSurg and Neurotechnology — Segment Revenue ($M) ($M)

Stryker MedSurg and Neurotechnology — Segment Revenue: $15,647M in FY2025, up 15.7% from a year earlier.

Latest, FY2025
15,647
Period ended Dec 31, 2025
Change on a year earlier
+15.7%
13,518 in FY2024
History
7 years
Since FY2019
Sources
3
Documents cited below

Where the FY2025 figure comes from

Source: Stryker Form 10-K — FY2025 (filed 2026-02-11) ↗

Reported in Postgres DB segment_values + FY2026Q3 Form 10-Q XBRL.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedMedSurg and Neurotechnology — Segment Revenue ($M) ($M)Year on yearSource
FY2025Dec 31, 202515,647+15.7%Stryker Form 10-K — FY2025 (filed 2026-02-11) ↗
FY2024Dec 31, 202413,518+11.1%Stryker Form 10-K — FY2024 (filed 2025-02-12) ↗
FY2023Dec 31, 202312,163+11.7%Stryker Form 10-K — FY2024 (filed 2025-02-12) ↗
FY2022Dec 31, 202210,893+14.2%Stryker Form 10-K — FY2024 (filed 2025-02-12) ↗
FY2021Dec 31, 20219,538+14.3%Stryker Form 10-K — FY2021 (filed 2022-02-11) ↗
FY2020Dec 31, 20208,345-1.5%Stryker Form 10-K — FY2021 (filed 2022-02-11) ↗
FY2019Dec 31, 20198,475–Stryker Form 10-K — FY2021 (filed 2022-02-11) ↗

Breakdown

What makes up medSurg and Neurotechnology — Segment Revenue

Cite this data

StockData. (2026). Stryker MedSurg and Neurotechnology — Segment Revenue ($M), annual FY2019–FY2025 [Data set]. Compiled from Stryker SEC filings and investor materials. https://stockdatahq.com/stocks/syk/kpis/db-seg-ms-rev

See every metric in the Stryker KPI table. Data updated Nov 2, 2026.